Shanghai Greenvalley Pharmaceutical Co., Ltd.   Report issue

For profit Phase 3 Phase 4
Founded: Shanghai China (1997)

Organization Overview

First Clinical Trial
2011
NCT01453569
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Shanghai Greenvalley Pharmaceutical Co., Ltd. | Shanghai Green Valley Pharmaceutical Co., Ltd.

Active Ingredients

Drugs in Phase 4 Trials (1)

sodium oligo-mannurarate (7 trials)

Drugs in Phase 3 Trials (1)

propolis (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Angina Pectoris (Phase 3)

Angina, Stable (Phase 3)

Cognitive Dysfunction (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 2